Status:
RECRUITING
Contrast Echocardiography During Exercise to Assess Pulmonary Blood Volume
Lead Sponsor:
Mayo Clinic
Conditions:
Heart Failure
Pulmonary Vascular Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate whether pulmonary blood volume (PBV) derived from contrast echocardiography can serve as a non-invasive surrogate for invasive pulmonary artery wedge pressure ...
Eligibility Criteria
Inclusion
- Patients referred to the cardiac catheterization laboratory for invasive exercise right heart catheterization for evaluating exertional dyspnea. Investigators will include patients with normal or low EF, and across the spectrum of pulmonary hypertension severity.
Exclusion
- Patient inability or unwillingness to undergo echocardiography including a contrast method, or if echocardiography would, in the opinion of the investigator, somehow compromise the quality of data acquisition for the clinical case.
- Prior adverse reaction to echo contrast administration
Key Trial Info
Start Date :
July 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06195059
Start Date
July 30 2024
End Date
November 1 2026
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905